Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatches Switz Regulatory News (WOSG)

Share Price Information for Watches Switz (WOSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 334.40
Bid: 315.00
Ask: 359.00
Change: 0.00 (0.00%)
Spread: 44.00 (13.968%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 334.40
WOSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 Dec 2023 13:00

RNS Number : 3728W
Watches of Switzerland Group PLC
11 December 2023
 

WATCHES OF SWITZERLAND GROUP PLC (the 'Company')

DIRECTOR/PDMR SHAREHOLDING

 

The Company announces that it has awarded on 11 December 2023 nil cost options to its Executive Directors under the Company's 2019 Long Term Incentive Plan (the 'Awards').

 

The Performance Target for the Awards consists of the following elements:

· 80% of the Awards will Vest depending on the Company's Cumulative EPS performance against targets (the "EPS Performance Award").

· 20% of the Awards will Vest depending on the Company's Average ROCE performance against targets (the "ROCE Performance Award"). 

The EPS Performance Awards will Vest as follows

 

Cumulative EPS

Percentage of Award Vesting

Less than 189.9 pence

Nil

189.9 pence

16%

Between 189.9 pence and 209.9 pence

Between 16% and 80% on a straight-line basis

209.9 pence or more

80%

 

The ROCE Performance Awards will Vest as follows

Average ROCE

Percentage of Award Vesting

Less than 23.7%

Nil

23.7%

4%

Between 23.7% and 26.2%

Between 4% and 20% on a straight-line basis

26.2% or more

20%

 

The Awards will vest in July 2026 after a performance measurement period of three financial years (FY 2024 to FY 2026) and there is a Holding Period of two years from the vesting date.

 

The following information is given in accordance with Article 19.3 of the Market Abuse Regulation and is made on behalf of Brian Duffy a PDMR, in the Watches of Switzerland Group PLC under article 19.1 of the Market Abuse Regulation ('MAR').

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Brian Duffy

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Watches of Switzerland Group PLC

b)

 

LEI

2138008ZOT5K9PJW7168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.0125 each

Identification code

GB00BJDQQ870

b)

 

Nature of the transaction

 

 

An award of nil cost options, granted under the Company's 2019 Long Term incentive Plan.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£nil

149,365

d)

 

Aggregated information

- Aggregated volume

149,365

- Price

£nil

e)

 

Date of the transaction

 

11 December 2023

f)

 

Place of the transaction

XLON

 

The following information is given in accordance with Article 19.3 of the Market Abuse Regulation and is made on behalf of Anders Romberg a PDMR, in the Watches of Switzerland Group PLC under article 19.1 of the Market Abuse Regulation ('MAR').

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Anders Romberg

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Watches of Switzerland Group PLC

b)

 

LEI

2138008ZOT5K9PJW7168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.0125 each

Identification code

GB00BJDQQ870

b)

 

Nature of the transaction

 

 

An award of nil cost options, granted under the Company's 2019 Long Term incentive Plan.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£nil

99,327

d)

 

Aggregated information

- Aggregated volume

99,327

- Price

£nil

e)

 

Date of the transaction

11 December 2023

f)

 

Place of the transaction

XLON

 

Enquiries:

Laura Battley Lucy Legh / Rob Walker / Joanna Clark 

Company Secretary and General Counsel Headland

T: 0207 317 4600 T: 0203 805 4822

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDBDDCUBDGXB
Date   Source Headline
26th Mar 20241:26 pmRNSHolding(s) in Company
22nd Feb 20245:24 pmRNSHolding(s) in Company
19th Feb 20245:12 pmRNSHolding(s) in Company
9th Feb 20244:56 pmRNSDirector/PDMR Shareholding
9th Feb 202410:59 amRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSQ3 FY24 Trading Update
22nd Jan 20243:30 pmRNSHolding(s) in Company
19th Jan 20243:00 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSTrading Update
11th Dec 20231:00 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSH1 FY24 Results
27th Nov 20237:00 amRNSNotice of H1 FY24 Results
7th Nov 20237:00 amRNSLong Range Plan
7th Nov 20237:00 amRNSQ2 FY24 Trading Update
18th Oct 20233:09 pmRNSHolding(s) in Company
12th Oct 20234:14 pmRNSHolding(s) in Company
12th Oct 20231:15 pmRNSNotice of Trading Update and Long Range Plan
11th Oct 20235:27 pmRNSHolding(s) in Company
10th Oct 20235:35 pmRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirector Declaration
6th Oct 20235:35 pmRNSHolding(s) in Company
26th Sep 20236:15 pmRNSHolding(s) in Company
22nd Sep 20235:15 pmRNSHolding(s) in Company
5th Sep 202310:32 amRNSHolding(s) in Company
4th Sep 20237:00 amRNSDirector/PDMR Shareholding
4th Sep 20237:00 amRNSDirector/PDMR Shareholding
4th Sep 20237:00 amRNSDirector/PDMR Shareholding
4th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20239:50 amRNSResult of AGM
30th Aug 20234:02 pmRNSHolding(s) in Company
29th Aug 20234:18 pmRNSHolding(s) in Company
25th Aug 20237:45 amRNSResponse to acquisition of Rolex SA of Bucherer SA
10th Aug 20237:00 amRNSQ1 FY24 Trading Update
4th Aug 20234:24 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSNotice of Q1 FY24 Trading Update
31st Jul 20232:23 pmRNSAnnual Financial Report
21st Jul 202310:56 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSFY23 Results
14th Jun 20232:13 pmRNSHolding(s) in Company
17th May 20237:00 amRNSQ4 FY23 Trading Update
12th May 20232:30 pmRNSDirector Declaration
3rd May 20237:00 amRNSDirectorate Change
25th Apr 20238:22 amRNSDirector Declaration
18th Apr 20237:00 amRNSNotice of Q4 FY23 Trading Update
13th Feb 20232:16 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSQ3 FY23 Trading Update
17th Jan 20237:00 amRNSNotice of Q3 FY23 Trading Update
14th Dec 20227:00 amRNSH1 FY23 Results
8th Dec 20224:47 pmRNSHolding(s) in Company - Replacement
8th Dec 202211:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.